Up-to-date results on survival of patients with melanoma in Germany

British Journal of Dermatology

Volumn 167, Issue 3, 2012, Pages 606-612

  Eisemann, N ^a   Jansen, L ^b   Holleczek, B ^c   Waldmann, A ^a   Luttmann, S ^d   Emrich, K ^e   Hauschild, A ^f   Brenner, H ^b   Katalinic, A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c SAARLAND CANCER REGISTRY   (Germany)

^d LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^e Institute of Medical Biostatistics Epidemiology and Informatics   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SURVIVAL; CUTANEOUS MELANOMA; DISEASE SEVERITY; FEMALE; GERMANY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; FEMALE; GERMANY; HUMANS; MALE; MELANOMA; MIDDLE AGED; MORTALITY; REGISTRIES; SEX DISTRIBUTION; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84865599325     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11039.x     Document Type: Article

References (36)

1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon: International Agency for Research on Cancer, 2010.
2. Robert Koch Institute. Cancer in Germany 2007/2008. Incidence and Trends, 8th edn. Berlin: Robert Koch Institute and the Association of Population-based Cancer Registries in Germany, 2012.
3. Tumour Registry Munich. Survival C43: Malignant Melanoma. Munich: Tumour Registry Munich, 2007, updated 2011.
4. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute, 2011.
5. Gondos A, Bray F, Brewster D, et al. Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. Eur J Cancer 2008; 44: 1463-75.
6. Karim-Kos HE, de Vries E, Soerjomataram I, et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44: 1345-89.
7. Hiripi E, Gondos A, Emrich K, et al. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol 2012; 23: 472-9.
8. Wittekind C, Wagner G,. TNM-Klassifikation Maligner Tumoren, 5th edn. Berlin: Springer-Verlag, 1997.
9. Wittekind C, Meyer HJ, Bootz F,. TNM Klassifikation Maligner Tumoren, 6th edn. Berlin: Springer-Verlag, 2002.
10. de Vries E, Nijsten TE, Visser O, et al. Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. Ann Oncol 2008; 19: 583-9. (Pubitemid 351325683)
11. Henson DE, Ries LA,. The relative survival rate. Cancer 1995; 76: 1687-8.
12. Ederer F, Heise H,. Instructions to IBM 650 Programmers in Processing Survival Computations. Methodological Notes No. 10. Bethesda, MD: End Results Evaluation Section, National Cancer Institute, 1959.
13. Brenner H, Gefeller O, Hakulinen T,. Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004; 40: 326-35. (Pubitemid 38121268)
14. Brenner H, Soderman B, Hakulinen T,. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 2002; 31: 456-62. (Pubitemid 34537812)
15. Brenner H, Hakulinen T,. Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 2002; 20: 826-32. (Pubitemid 34111392)
16. Corazziari I, Quinn M, Capocaccia R,. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004; 40: 2307-16. (Pubitemid 39348882)
17. Brenner H, Hakulinen T,. Up-to-date and precise estimates of cancer patient survival: model-based period analysis. Am J Epidemiol 2006; 164: 689-96. (Pubitemid 44453498)
18. Verdecchia A, Santaquilani M, Sant M,. Survival for cancer patients in Europe. Ann Ist Super Sanita 2009; 45: 315-24.
19. R Development Core Team. R: A Language and Environment for Statistical Computing, 2.13.0. Vienna: R Foundation for Statistical Computing, 2011.
20. Holleczek B, Gondos A, Brenner H,. periodR-an R package to calculate long-term cancer survival estimates using period analysis. Methods Inf Med 2009; 48: 123-8.
21. Brenner H, Gefeller O, Hakulinen T,. A computer program for period analysis of cancer patient survival. Eur J Cancer 2002; 38: 690-5. (Pubitemid 34251393)
22. Gondos A, Bray F, Hakulinen T, et al. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol 2009; 20: 564-73.
23. Cockburn M, Peng D, Key C,. Melanoma. In: SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics (, Ries LAG, Young JL, Keel GE, et al., eds). NIH Pub. No. 07-6215. Bethesda, MD: National Cancer Institute, SEER Program, 2007; 93-100.
24. Levi F, Randimbison L, La Vecchia C, et al. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland. Int J Cancer 1998; 78: 315-19. (Pubitemid 28445368)
25. Garbe C, Buttner P, Bertz J, et al. Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer 1995; 75: 2492-8.
26. MacKie RM,. Malignant melanoma: clinical variants and prognostic indicators. Clin Exp Dermatol 2000; 25: 471-5.
27. MacKie RM, Bray CA, Hole DJ, et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 2002; 360: 587-91. (Pubitemid 35232190)
28. LeBoit PE, Burg G, Weedon D, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours. Lyon: IARC Press, 2006.
29. Liu W, Dowling JP, Murray WK, et al. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol 2006; 142: 1551-8. (Pubitemid 44969210)
30. Downing A, Newton-Bishop JA, Forman D,. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer 2006; 95: 91-5. (Pubitemid 43980560)
31. Koh HK, Michalik E, Sober AJ, et al. Lentigo maligna melanoma has no better prognosis than other types of melanoma. J Clin Oncol 1984; 2: 994-1001. (Pubitemid 14026255)
32. Buettner PG, Leiter U, Eigentler TK, et al. Development of prognostic factors and survival in cutaneous melanoma over 25 years: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Cancer 2005; 103: 616-24.
33. Richard MA, Grob JJ, Avril MF, et al. Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol 1999; 135: 269-74. (Pubitemid 29159208)
34. Cai SR, Zhang SZ, Zhu HH, et al. Barriers to colorectal cancer screening: a case-control study. World J Gastroenterol 2009; 15: 2531-6.
35. Scheffer S, Dauven S, Sieverding M,. Soziodemografische Unterschiede in der Teilnahme an Krebsfrüherkennungsuntersuchungen (KFU) in Deutschland-eine Übersicht. Gesundheitswesen 2006; 68: 139-46.
36. Breitbart EW, Waldmann A, Nolte S, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 2012; 66: 201-11.